Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Torsten Haferlach

Showing results (181-190 of 596) with videos related to

Pageof 60
Sort By:
Leukemia & Lymphoma|May 26, 2021
Comprehensive analysis of the genetic landscape of 21 cases with blastic plasmacytoid dendritic cell neoplasm by whole genome and whole transcriptome sequencingIsolde Summerer, Wencke Walter, Manja Meggendorfer, et al.
Genes, Chromosomes & Cancer|October 24, 2015
Genetic characterization of T-PLL reveals two major biologic subgroups and JAK3 mutations as prognostic markerAnna Stengel, Wolfgang Kern, Melanie Zenger, et al.
British Journal of Haematology|January 10, 2012
Monoclonal B-cell lymphocytosis is closely related to chronic lymphocytic leukaemia and may be better classified as early-stage CLLWolfgang Kern, Ulrike Bacher, Claudia Haferlach, et al.
Cytometry. Part B, Clinical Cytometry|April 18, 2012
Evaluation of flow cytometric assessment of myeloid nuclear differentiation antigen expression as a diagnostic marker for myelodysplastic syndromes in a series of 269 patientsFrauke Bellos, Tamara Alpermann, Elena Gouberman, et al.
Cancer Genetics|November 8, 2019
Cytogenetic and molecular genetic characterization of KMT2A-PTD positive acute myeloid leukemia in comparison to KMT2A-Rearranged acute myeloid leukemiaCalogero Vetro, Torsten Haferlach, Manja Meggendorfer, et al.
Leukemia & Lymphoma|January 19, 2019
Evidence of clonality in cases of hypereosinophilia of undetermined significanceChristian Pohlkamp, Calogero Vetro, Frank Dicker, et al.
Journal of the National Cancer Institute|July 21, 2005
Re: Prognostic significance of a short sequence insertion in the MCL-1 promoter in chronic lymphocytic leukemiaFrank Dicker, Sonja Rauhut, Alexander Kohlmann, et al.
Haematologica|June 14, 2006
A combination of cytomorphology, cytogenetic analysis, fluorescence in situ hybridization and reverse transcriptase polymerase chain reaction for establishing clonality in cases of persisting hypereosinophiliaUlrike Bacher, Andreas Reiter, Torsten Haferlach, et al.
Leukemia & Lymphoma|July 20, 2021
The diverse landscape of fusion transcripts in 25 different hematological entitiesClaudia Haferlach, Wencke Walter, Anna Stengel, et al.
Haematologica|August 3, 2019
Molecular characterization of acute myeloid leukemia patients who relapse more than 3 years after diagnosis: an exome sequencing study of 31 patientsLuise Hartmann, Claudia Haferlach, Manja Meggendorfer, et al.
Pageof 60

Showing results (181-190 of 596) with videos related to

Sort By:
Pageof 60
Leukemia & Lymphoma|May 26, 2021
Comprehensive analysis of the genetic landscape of 21 cases with blastic plasmacytoid dendritic cell neoplasm by whole genome and whole transcriptome sequencingIsolde Summerer, Wencke Walter, Manja Meggendorfer, et al.
Genes, Chromosomes & Cancer|October 24, 2015
Genetic characterization of T-PLL reveals two major biologic subgroups and JAK3 mutations as prognostic markerAnna Stengel, Wolfgang Kern, Melanie Zenger, et al.
British Journal of Haematology|January 10, 2012
Monoclonal B-cell lymphocytosis is closely related to chronic lymphocytic leukaemia and may be better classified as early-stage CLLWolfgang Kern, Ulrike Bacher, Claudia Haferlach, et al.
Cytometry. Part B, Clinical Cytometry|April 18, 2012
Evaluation of flow cytometric assessment of myeloid nuclear differentiation antigen expression as a diagnostic marker for myelodysplastic syndromes in a series of 269 patientsFrauke Bellos, Tamara Alpermann, Elena Gouberman, et al.
Cancer Genetics|November 8, 2019
Cytogenetic and molecular genetic characterization of KMT2A-PTD positive acute myeloid leukemia in comparison to KMT2A-Rearranged acute myeloid leukemiaCalogero Vetro, Torsten Haferlach, Manja Meggendorfer, et al.
Leukemia & Lymphoma|January 19, 2019
Evidence of clonality in cases of hypereosinophilia of undetermined significanceChristian Pohlkamp, Calogero Vetro, Frank Dicker, et al.
Journal of the National Cancer Institute|July 21, 2005
Re: Prognostic significance of a short sequence insertion in the MCL-1 promoter in chronic lymphocytic leukemiaFrank Dicker, Sonja Rauhut, Alexander Kohlmann, et al.
Haematologica|June 14, 2006
A combination of cytomorphology, cytogenetic analysis, fluorescence in situ hybridization and reverse transcriptase polymerase chain reaction for establishing clonality in cases of persisting hypereosinophiliaUlrike Bacher, Andreas Reiter, Torsten Haferlach, et al.
Leukemia & Lymphoma|July 20, 2021
The diverse landscape of fusion transcripts in 25 different hematological entitiesClaudia Haferlach, Wencke Walter, Anna Stengel, et al.
Haematologica|August 3, 2019
Molecular characterization of acute myeloid leukemia patients who relapse more than 3 years after diagnosis: an exome sequencing study of 31 patientsLuise Hartmann, Claudia Haferlach, Manja Meggendorfer, et al.
Pageof 60